Therapeutic Plasma Exchange to Alleviate Hyperinflammatory Condition During Severe Covid-19 Infections

NACompletedINTERVENTIONAL
Enrollment

21

Participants

Timeline

Start Date

April 19, 2021

Primary Completion Date

December 19, 2022

Study Completion Date

December 19, 2022

Conditions
Intensive Care UnitsARDS, HumanCovid19
Interventions
OTHER

Therapeutic plasma exchange : 3 sessions in 3 consecutive days (day 1 to day 3)

"Therapeutic plasma exchange (TPE) ; 3 sessions in 3 consecutive days (Day 1 to Day 3) in intensive care unit in addition to usual treatments.~Plasma removed is replaced by thawed fresh frozen plasma. Plasma blood volume exchanged : 1.2 Apheresis type: centrifugation"

OTHER

Usual treatments in intensive care unit according to the current state of knowledge

Usual treatments of patients in intensive care unit with hyperinflammatory condition due to Covid-19 infection consist in supporting respiratory function, oxygen supplementation, non invasive ventilation, invasive ventilation, antibiotic, vasopressive support and corticosteroids (in absence of bacterial secondary infection)

Trial Locations (8)

26216

Groupement Hospitalier Porte de Valence - Montélimar, Montélimar

69003

Hôpital Edouard Herriot, Lyon

69004

Hôpital Croix Rousse, Lyon

69100

Medipole Villeurbanne, Villeurbanne

69310

Centre Hospitalier Lyon Sud, Pierre-Bénite

69337

Clinique de la Sauvegarde, Lyon

71100

Centre Hospitalier William Morey, Chalon-sur-Saône

75013

Hôpital Pitié Salpétrière - Assistante Publique des Hôpitaux de Paris, Paris

All Listed Sponsors
lead

Hospices Civils de Lyon

OTHER